AVITHRAPID project meets HERA
On 3 March 2025, the AVITHRAPID consortium met HERA during the first AVITHRAPID seminar to foster collaboration and explore new opportunities in the domain of antivirals as response against pandemic infectious diseases. During the online meeting, Prof. Bjoern Windshuegel and Prof. Vincenzo Summa of the Consortium led the introduction of activities and services of AVITHRAPID […]
AVITHRAPID Launches ‘AVITHRAPID SEMINARS’ to Advance Pandemic Preparedness and Antiviral Research
AVITHRAPID, the cutting-edge European initiative dedicated to accelerating antiviral research and pandemic preparedness, is proud to announce the launch of AVITHRAPID SEMINARS—a dynamic series of expert-driven discussions uniting regulatory authorities, pharmaceutical industry leaders, European projects, and key stakeholders. The first closed-door seminar is scheduled for Monday, March 3, 2025, featuring a high-level discussion with HERA […]
Workshop ” Biology and Applications of Extracellular Vesicles”
On Wednesday 12 February 2025, a workshop entitled “Biology and Applications of Extracellular Vesicles” was held in the Aula Magna “Carlo Perone Pacifico”, of the Department of Agricultural and Forestry Sciences, University of Tuscia, partner of Avithrapid consortium. It was organized by Professors Umberto Bernabucci and Nicola Lacetera, as Scientific Directors, respectively, of the PRIN […]
AVITHRAPID Joins Bluesky: A New Space to Connect with the Scientific Community
AVITHRAPID is a project designed to tackle global challenges in antiviral research through an innovative and multidisciplinary approach. Our vision extends beyond laboratory work and scientific publications—we believe in fostering connections, engaging with the scientific community, and sharing our work with a wider audience. For this reason, we are pleased to announce our official presence […]
Breaking News: AVITHRAPID Publishes Key Data to Accelerate Drug Development for Dengue
Breaking News: AVITHRAPID Publishes Key Data to Accelerate Drug Development for Dengue AVITHRAPID has announced a breakthrough in the fight against dengue fever by publishing critical protein models for all four dengue virus (DENV) serotypes. These open-access data represent a transformative step in identifying high-potential viral targets for drug development, offering the global scientific community […]